摘要
Psoriasis is a common chronic recurrent inflammatory disease.Plaque psoriasis accounts for more than 90%of psoriasis patients.Currently,no therapies are curative.Biologics have greatly improved the clinical efficacy and potentially provide a better long-term safety profile,with respect to toxicity to major organs,than conventional treatments;however,relapse after treatment withdrawal is still an important issue.Although maintenance treatment is recommended in most guidelines,treatment withdrawal occurs quite frequently in real-world clinical practice.Thus,the time to relapse is an important consideration when choosing among the different therapies.
基金
the 2019 Grant of Milstein Medical Asian American Partnership Foundation.